Novarex노바렉스
194700 · KOSDAQ · ₩194700 · 노바렉스
- Market cap
- ₩166B
- Enterprise value
- ₩149B
- P/E
- 3.9×
- P/B
- 0.6×
- Dividend yield
- 4.4%
- ROE
- 15.9%
- Net margin
- 9.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−50.8% from the high
₩8,910Today: ₩8,910 – ₩9,240₩18,450
Returns
- 1W−6.7%
- 1M−10.2%
- 3M−28.4%
- 6M−37.9%
- YTD−35.2%
- 1Y−48.5%
- Volume today
- 61,983
- 1.6× the 20-day average
- Traded today
- ₩560M
- Listed shares
- 18,254,848
- EPS (12 months)
- ₩2,341
- Earnings yield 25.8%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 48 of 100 (50 is a normal day for this stock).
- MomentumWeak-10.2% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Novarex stock overview
Novarex (노바렉스, KRX: 194700) is listed on KOSDAQ, in the Food & Beverage sector. The company manufactures and sells health functional foods, along with health functional food ingredients, and engages in import and export of these products. Its shares closed at ₩9,070 on Oct 27, 2026, down 0.33% on the day, giving it a market value of ₩166B.
Key facts
- Market cap
- ₩166B
- Sector
- Food & Beverage
- Latest price change
- −0.33%
- As of
- Oct 27, 2026
- Main business
- The company manufactures and sells health functional foods, along with health functional food ingredients, and engages in import and export of these products.
Quick answers about Novarex
- What does Novarex do?
- The company manufactures and sells health functional foods, along with health functional food ingredients, and engages in import and export of these products. It is known for ODM/OEM production based on its individually recognized ingredients, and sells through large retail chains, direct selling, network marketing, and direct overseas exports to B2B customers. Its products are sold domestically in Korea and exported abroad.
- What is the market cap of Novarex?
- The market capitalisation of Novarex was ₩166B at the close on Oct 27, 2026.
- Who are the largest shareholders of Novarex?
- According to the latest official filings, the largest reported holders are Kwon Seok-hyeong (32.02%, as of Oct 20, 2026); Kwon Su-hye (8.25%, as of Dec 24, 2025); Kwon Soo-hee (5.87%, as of Dec 24, 2025).
- When is the next earnings report from Novarex?
- Korean companies rarely announce results dates in advance. Based on when Novarex filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Novarex?
- Yes. The National Pension Service held 0.65% of Novarex shares as of Dec 31, 2025.
Company profile
The company manufactures and sells health functional foods, along with health functional food ingredients, and engages in import and export of these products. It is known for ODM/OEM production based on its individually recognized ingredients, and sells through large retail chains, direct selling, network marketing, and direct overseas exports to B2B customers. Its products are sold domestically in Korea and exported abroad.
Written by AI from the company's latest annual report.
- Korean name
- 노바렉스
- Sector
- Food & Beverage
- Themes
- K-food & ramen
- CEO
- 권석형, 권수혜(각자대표)
- Founded
- Nov 2008
- Listed
- Nov 2018
- Listed shares
- 18,254,848
- Fiscal year ends
- Month 12
- Website
- www.novarex.co.kr
Similar companies
- Samyang Foods003230 · ₩8.5T₩1,133,000+1.52%
- Orion271560 · ₩4.4T₩111,500−1.33%
- CJ Cheiljedang097950 · ₩2.5T₩168,700−0.71%
- Nongshim004370 · ₩2.4T₩393,0000.00%
- Otoki007310 · ₩1.2T₩307,500−0.97%
- Hite Jinro000080 · ₩1.1T₩15,660−1.20%
- Lotte Wellfood280360 · ₩1.1T₩118,500−0.08%
- Lotte Chilsung Beverage005300 · ₩881B₩95,000+1.39%
Recent filings
See all- 5%+ holding reportOct 20, 2026
- 5%+ holding reportAug 27, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportAug 10, 2026
- Insider shareholding reportAug 4, 2026
Titles in Korean until English translations are added.
Also known as: Novarex / 노바렉스 / 194700 / KRX:194700
Source: KRX statistical information